Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety.
bioRxiv · 2024
Last updated 2026-05-28In mice, the weight-loss drug liraglutide may reduce hunger by activating specific brain cells called Trh+ neurons, which then suppress other neurons (AgRP) linked to appetite. These Trh+ neurons respond to liraglutide and, when activated, lower food intake and body weight. Blocking these Trh+ neurons led to overeating, weight gain, and weakened liraglutide’s effects on weight.
AI summary of the abstract below.
| Journal | bioRxiv, 2024 |
|---|---|
| Citations | 7 |
| Relative citation ratio | 1.20 |
| NIH percentile | 57 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
Liraglutide and other agonists of the glucagon-like peptide 1 receptor (GLP-1RAs) are effective weight loss drugs, but how they suppress appetite remains unclear. One potential mechanism is by activating neurons which inhibit hunger-promoting Agouti-related peptide (AgRP) neurons of the arcuate hypothalamus (Arc). To identify these afferents, we developed a method combining rabies-based connectomics with single-nuclei transcriptomics. Applying this method to AgRP neurons predicted at least 21 afferent subtypes in the mouse mediobasal and paraventricular hypothalamus. Among these are Trh+ Arc neurons, inhibitory neurons which express the Glp1r gene and are activated by the GLP-1RA liraglutide. Activating Trh+ Arc neurons inhibits AgRP neurons and feeding in an AgRP neuron-dependent manner. Silencing Trh+ Arc neurons causes over-eating and weight gain and attenuates liraglutide's effect on body weight. Our results demonstrate a widely applicable method for molecular connectomics, comprehensively identify local inputs to AgRP neurons, and reveal a circuit through which GLP-1RAs suppress appetite.
Verbatim abstract via PubMed 37961449 ↗